Acellular Pertussis Completed Phase 3 Trials for Hepatitis B Vaccine (Recombinant) (DB11627)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02096263Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsPrevention
NCT00879827Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsPrevention